STOCK TITAN

BIO-TECHNE ANNOUNCES IVDR CERTIFIED HEMATOLOGY CONTROLS AND CALIBRATORS

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Very Positive)
Tags

Bio-Techne (NASDAQ: TECH) has achieved IVDR certification for its R&D Systems Hematology Controls and Calibrators, confirming compliance with European Union regulations for in-vitro diagnostic devices. This certification underscores the products' high quality, accuracy, precision, and reliability. It represents a significant milestone in Bio-Techne's dedication to supporting healthcare professionals with top-tier laboratory components. The certified Hematology Controls and Calibrators are vital for ensuring accurate patient testing in laboratories, meeting stringent hematology standards.

Bio-Techne (NASDAQ: TECH) ha ottenuto la certificazione IVDR per i suoi Controlli e Calibratori di Ematologia R&D Systems, confermando la conformità alle normative dell'Unione Europea per i dispositivi diagnostici in vitro. Questa certificazione sottolinea l'alta qualità, l'accuratezza, la precisione e l'affidabilità dei prodotti. Rappresenta un traguardo significativo nell'impegno di Bio-Techne nel supportare i professionisti del settore sanitario con componenti di laboratorio di prima classe. I Controlli e i Calibratori di Ematologia certificati sono fondamentali per garantire test accurati sui pazienti nei laboratori, rispettando rigorosi standard di ematologia.

Bio-Techne (NASDAQ: TECH) ha obtenido la certificación IVDR para sus Controles y Calibradores de Hematología de R&D Systems, confirmando el cumplimiento de las regulaciones de la Unión Europea para dispositivos de diagnóstico in vitro. Esta certificación subraya la alta calidad, precisión, exactitud y fiabilidad de los productos. Representa un hito significativo en el compromiso de Bio-Techne de apoyar a los profesionales de la salud con componentes de laboratorio de primera categoría. Los Controles y Calibradores de Hematología certificados son vitales para garantizar pruebas precisas de pacientes en laboratorios, cumpliendo con estrictos estándares de hematología.

Bio-Techne (NASDAQ: TECH)는 R&D Systems 혈액학 제어 및 교정기기에 대해 IVDR 인증을 획득하여 유럽 연합의 체외 진단 장치 규정을 준수함을 확인했습니다. 이 인증은 제품의 높은 품질, 정확성, 정밀성 및 신뢰성을 강조합니다. 이는 Bio-Techne가 최상급 실험실 구성 요소로 의료 전문가를 지원하겠다는 약속의 중요한 이정표를 나타냅니다. 인증된 혈액학 제어 및 교정기는 엄격한 혈액학 표준을 충족하여 실험실에서 정확한 환자 검사 보장을 위해 필수적입니다.

Bio-Techne (NASDAQ: TECH) a obtenu la certification IVDR pour ses Contrôles et Calibrateurs d'Hématologie R&D Systems, confirmant ainsi sa conformité aux réglementations de l'Union Européenne pour les dispositifs de diagnostic in vitro. Cette certification souligne la haute qualité, la précision, l'exactitude et la fiabilité des produits. Elle représente une étape importante dans l'engagement de Bio-Techne à soutenir les professionnels de la santé avec des composants de laboratoire de premier plan. Les Contrôles et Calibrateurs d'Hématologie certifiés sont essentiels pour garantir des tests précis sur les patients dans les laboratoires, respectant des normes hématologiques strictes.

Bio-Techne (NASDAQ: TECH) hat die IVDR-Zertifizierung für seine R&D Systems Hämatologie-Kontrollen und -Kalibratoren erhalten und bestätigt damit die Einhaltung der Vorschriften der Europäischen Union für In-vitro-Diagnosetests. Diese Zertifizierung hebt die hohe Qualität, Genauigkeit, Präzision und Zuverlässigkeit der Produkte hervor. Sie stellt einen bedeutenden Meilenstein im Engagement von Bio-Techne dar, Gesundheitsfachkräfte mit hochwertigen Laborbauteilen zu unterstützen. Die zertifizierten Hämatologie-Kontrollen und -Kalibratoren sind entscheidend für die Gewährleistung genauer Patiententests in Laboren und erfüllen strenge hämatologische Standards.

Positive
  • Achieved IVDR certification for Hematology Controls and Calibrators.
  • Compliance with European Union regulations for in-vitro diagnostic devices.
  • Enhanced product quality, accuracy, precision, and reliability.
Negative
  • None.

Insights

The IVDR certification for Bio-Techne's hematology controls represents a significant regulatory milestone that strengthens the company's position in the European diagnostics market. This Class C certification, which is among the higher risk classifications under IVDR, validates the product's quality and reliability for clinical laboratories.

The certification timing is strategic, as laboratories across Europe are transitioning to meet stricter IVDR requirements. This early compliance gives Bio-Techne a competitive advantage in the $7.6 billion global hematology controls market. The certification will likely drive increased market penetration in Europe and potentially boost market share, as non-certified products will be gradually phased out of the market.

R&D Systems Hematology Controls and Calibrators has completed the Class C Certification under the new European Union In Vitro Diagnostic Regulation

MINNEAPOLIS, Nov. 11, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) has recently achieved In Vitro Diagnostic Regulation (IVDR) certification for its R&D Systems Hematology Controls and Calibrators. This certification confirms that the products comply with the regulations and guidelines set forth by the European Union for in-vitro diagnostic devices.

This IVDR certification demonstrates the product's exceptional quality standards, ensuring high levels of accuracy, precision, and reliability. It marks an important milestone in Bio-Techne's commitment to meeting the needs of healthcare professionals.

Hematology Controls and Calibrators are essential components in the laboratory setting that support accuracy in patient testing. With the IVDR certification, customers can be assured that Bio-Techne's R&D Systems Hematology Controls and Calibrators meet the rigorous standards required in hematology.

"At Bio-Techne, we take pride in designing and manufacturing products that enable researchers and healthcare professionals to improve patients' lives. We are thrilled to be able to offer IVDR certified Hematology Controls and Calibrators to our customers, ensuring they receive the highest quality products," said Dr. Matt McManus, President of Bio-Techne's Diagnostics & Spatial Biology Segment.

About Bio-Techne Corporation
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With thousands of products in its portfolio, Bio-Techne generated approximately $1.2 billion in net sales in fiscal 2024 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at: Facebook, LinkedIn, Twitter or YouTube.

Contact: David Clair, Vice President, Investor Relations & Corporate Development
david.clair@bio-techne.com
612-656-4416

BT Logo (PRNewsfoto/Bio-Techne Corporation)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-announces-ivdr-certified-hematology-controls-and-calibrators-302295034.html

SOURCE Bio-Techne Corporation

FAQ

What certification did Bio-Techne's Hematology Controls and Calibrators achieve?

Bio-Techne's Hematology Controls and Calibrators achieved IVDR certification.

What does IVDR certification mean for Bio-Techne's products?

IVDR certification confirms that Bio-Techne's products comply with European Union regulations for in-vitro diagnostic devices, ensuring high quality, accuracy, precision, and reliability.

Why is the IVDR certification important for Bio-Techne's Hematology Controls and Calibrators?

The IVDR certification is important because it assures customers that Bio-Techne's Hematology Controls and Calibrators meet rigorous hematology standards, supporting accurate patient testing.

How does the IVDR certification impact Bio-Techne's commitment to healthcare professionals?

The IVDR certification demonstrates Bio-Techne's commitment to providing high-quality products that meet the needs of healthcare professionals by ensuring accuracy and reliability in laboratory testing.

Bio-Techne Corp.

NASDAQ:TECH

TECH Rankings

TECH Latest News

TECH Stock Data

12.07B
158.89M
1.04%
99.35%
2.27%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
MINNEAPOLIS